Astragaloside

CAS# 17429-69-5

Astragaloside

Catalog No. BCN5959----Order now to get a substantial discount!

Product Name & Size Price Stock
Astragaloside: 5mg $17 In Stock
Astragaloside: 10mg Please Inquire In Stock
Astragaloside: 20mg Please Inquire Please Inquire
Astragaloside: 50mg Please Inquire Please Inquire
Astragaloside: 100mg Please Inquire Please Inquire
Astragaloside: 200mg Please Inquire Please Inquire
Astragaloside: 500mg Please Inquire Please Inquire
Astragaloside: 1000mg Please Inquire Please Inquire

Quality Control of Astragaloside

Number of papers citing our products

Chemical structure

Astragaloside

3D structure

Chemical Properties of Astragaloside

Cas No. 17429-69-5 SDF Download SDF
PubChem ID 5488387 Appearance Yellow powder
Formula C28H32O17 M.Wt 640.55
Type of Compound Flavonoids Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
SMILES COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)COC5C(C(C(C(O5)CO)O)O)O)O)O)O)O
Standard InChIKey GPZLFWVUSQREQH-QDYVESOYSA-N
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Astragaloside

The root of Astragalus membranaceus (Fisch.) Bunge

Biological Activity of Astragaloside

Description1. Astragaloside may protect against brain contusion and neuronal apoptosis after TBI by attenuating microglia activation in male rats. 2. Astragaloside has several pharmacological actions on cardiovascular system, including positive inotropic, anti-arrhythmia and anti-oxidant activities; it also has anti-apoptotic activity, which may contribute to the improvement of clinical outcomes in treating myocarditis with pharmaceutics of Astragalus membranaceus. 3. Astragalosides-induced apoptosis in NB4 cells may be associated with down-regulation of the expression of BCL-2 and NF-κB, finally the relative activity of caspase-3 activated.
TargetsBcl-2/Bax | NF-kB | Caspase | NO | NOS | Trk receptor

Astragaloside Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Astragaloside Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Astragaloside

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 1.5612 mL 7.8058 mL 15.6116 mL 31.2232 mL 39.029 mL
5 mM 0.3122 mL 1.5612 mL 3.1223 mL 6.2446 mL 7.8058 mL
10 mM 0.1561 mL 0.7806 mL 1.5612 mL 3.1223 mL 3.9029 mL
50 mM 0.0312 mL 0.1561 mL 0.3122 mL 0.6245 mL 0.7806 mL
100 mM 0.0156 mL 0.0781 mL 0.1561 mL 0.3122 mL 0.3903 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Astragaloside

[Role of BCL-2, caspase-3 and NF-kappaB in astragaloside inducing apoptosis of human NB4 cells].[Pubmed:24989280]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Jun;22(3):703-6.

This study was purposed to investigate the apoptosis-inducing effect of Astragalosides on acute promyelocytic leukemia(APL) cell line NB4 and its mechanism. NB4 cells were treated with different concentrations (200, 300, 400 microg /ml) of Astragalosides for 48 h. The cell proliferation was assayed by using CCK-8 method; the cell apoptosis was analyzed by flow cytometry with Annexin V-FITE/PI double staining. The mRNA expression of BCL-2 and the relative activity of BCL-2, NF-kappaB and caspase-3 were detected by RT-PCR and Western blot, respectively. The results showed that after treated with Astragalosides for 48 h, Astragalosides inhibited NB4 cell proliferation in concentration-dependent way, the apoptosis rate of NB4 cells gradually elevated from 4.69% to 40.85% with the increasing of Astragalosides concentration. Simultaneously, the mRNA expression of BCL-2 was down-regulated, Western blot analysis showed that the protein expression levels of BCL-2 and NF-kappaB decreased after Astragalosides treatment, while caspase-3 protein expression level increased. It is concluded that the molecular mechanism of the Astragalosides-induced apoptosis in NB4 cells may be associated with down-regulation of the expression of BCL-2 and NF-kappaB, finally the relative activity of caspase-3 activated.

Protective effect of astragaloside on focal cerebral ischemia/reperfusion injury in rats.[Pubmed:20503469]

Am J Chin Med. 2010;38(3):517-27.

This study was to observe the neurological protective effects of Astragalosides (AST) on focal cerebral ischemia-reperfusion (I/R) injury in rats and to explore its possible mechanism. Male SD rats received right middle cerebral artery occlusion for 120 min and AST (40 mg/kg) was orally administered. The rats were decapitated 1, 3, 7, and 14 days after reperfusion. The neurological deficit score, infarct volume and water content of brain were measured; the activity of superoxide dismutase (SOD), lactate dehydrogenase (LDH) and nitric oxide synthase (NOS), and the content of malondialdehyde (MDA), lactate (LD) and nitric oxide (NO) of brain tissue were detected too. The expression of inducible nitric synthase (iNOS), nerve growth factor (NGF) and tropomyosin receptor kinase A (TrkA) mRNA were measured by RT-PCR or real-time PCR. AST could significantly reduce the neurological deficit score; infract volume and water content, increase SOD and LDH activities, decrease NOS activity and MDA, LD and NO content. AST treatment could down-regulate expression of iNOS mRNA, while, NGF and TrkA mRNA were up-regulated. Our data suggest that AST have the protective effects on focal cerebral ischemia in rats at the different reperfusion time points, the mechanism may be related to the antioxidation, regulated the expressions of iNOS, NGF and TrkA mRNA.

Astragaloside improves outcomes of traumatic brain injury in rats by reducing microglia activation.[Pubmed:25384449]

Am J Chin Med. 2014;42(6):1357-70.

Astragaloside (AST) is traditionally prescribed for the prevention and treatment of cerebrovascular diseases. We directly tested the therapeutic effects of AST in a rat model of traumatic brain injury (TBI). One hour after the onset of TBI rats were given Saline (1 ml/kg) or AST (20-80 mg/kg) via i.p. injection. AST causes the attenuation of TBI-induced cerebral contusion, neuronal apoptosis, and neurological motor dysfunction. TBI-induced microglial activation evidenced by the morphological transformation of microglia (or ameboid microglia) and the microglial overexpression of tumor necrosis factor-alpha was reduced by AST. Our results indicate that AST may protect against brain contusion and neuronal apoptosis after TBI by attenuating microglia activation in male rats.

Keywords:

Astragaloside,17429-69-5,Natural Products, buy Astragaloside , Astragaloside supplier , purchase Astragaloside , Astragaloside cost , Astragaloside manufacturer , order Astragaloside , high purity Astragaloside

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: